Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 378.00
-24.00 (-5.97%)
Oct 23, 2026, 1:44 PM IDT
Epitomee Medical Company Description
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel.
The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions.
Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.
Epitomee Medical Ltd
| Country | Israel |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 44 |
| CEO | Dolev Rafaeli |
Contact Details
Address: 17 Hatochon St Caesarea, 3079892 Israel | |
| Phone | 972 7 4740 0799 |
| Website | epitomeemedical.com |
Stock Details
| Ticker Symbol | EPIT |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | IL0011825911 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Dolev Rafaeli Ph.D. | Chief Executive Officer |
| Dr. Argil Cohen | Chief Executive Officer of Research & Development |
| Dr. Shimon Eckhouse Ph.D. | Co-Founder and Chairman of the Board |
| Maya Gabrieli | Chief Financial Officer |
| Gal Aharonowitz | Chief Operating Officer |
| Reggy Vadanin | Accountant |
| Alon Heth | Vice President of Sales and Marketing |
| Dr. Yael Kidan | Vice President of Clinical Affairs |